These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 9041048

  • 41. Parathyroid hormone induces E4bp4 messenger ribonucleic acid expression primarily through cyclic adenosine 3',5'-monophosphate signaling in osteoblasts.
    Ozkurt IC, Pirih FQ, Tetradis S.
    Endocrinology; 2004 Aug; 145(8):3696-703. PubMed ID: 15087429
    [Abstract] [Full Text] [Related]

  • 42. Glucocorticoids and 1,25-dihydroxyvitamin D3 regulate parathyroid hormone stimulation of adenosine 3',5'-monophosphate-dependent protein kinase in rat osteosarcoma cells.
    Titus L, Rubin JE, Lorang MT, Catherwood BD.
    Endocrinology; 1988 Sep; 123(3):1526-34. PubMed ID: 2456915
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells.
    Hömme M, Schmitt CP, Himmele R, Hoffmann GF, Mehls O, Schaefer F.
    Endocrinology; 2003 Jun; 144(6):2496-504. PubMed ID: 12746312
    [Abstract] [Full Text] [Related]

  • 46. Parathyroid hormone and parathyroid hormone-related peptide activate the Na+/H+ exchanger NHE-1 isoform in osteoblastic cells (UMR-106) via a cAMP-dependent pathway.
    Azarani A, Orlowski J, Goltzman D.
    J Biol Chem; 1995 Sep 29; 270(39):23166-72. PubMed ID: 7559463
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways.
    Krishnan AV, Cramer SD, Bringhurst FR, Feldman D.
    Endocrinology; 1995 Feb 29; 136(2):705-12. PubMed ID: 7835303
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Inhibition of serine/threonine protein phosphatases enhances agonist-stimulated cAMP accumulation in UMR 106 osteoblast-like cells.
    Kovacs CS, Chik CL, Li B, Karpinski E, Ho AK.
    Mol Cell Endocrinol; 1995 Apr 28; 110(1-2):9-16. PubMed ID: 7545625
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
    Lombardi G, Di Somma C, Rubino M, Faggiano A, Vuolo L, Guerra E, Contaldi P, Savastano S, Colao A.
    J Endocrinol Invest; 2011 Jul 28; 34(7 Suppl):18-22. PubMed ID: 21985975
    [Abstract] [Full Text] [Related]

  • 58. Parathyroid hormone-related protein regulates osteoclast inhibitory lectin expression via multiple signaling pathways in osteoblast-like cells.
    Zheng F, Liang H, Liu R, Quan JX, Li XX, Dai CL, Guo G, Zhang JY, Wang BL.
    Endocrine; 2009 Feb 28; 35(1):47-56. PubMed ID: 18987998
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.